Join the club for FREE to access the whole archive and other member benefits.

Summary of Max Unfried presentation at Longevity Med Summit

VitaDAO has already funded 17 projects - including research areas not supported by traditional government agencies


VitaDAO is focused on funding longevity research.

Academics spend a lot of time writing non-ambitious grants.

Research data isn’t always shared.

Decentralised science aims to create a better incentive system, ensure replication and accelerate scientific discovery.

The potential market for longevity research is estimated to be in the trillions of dollars.

Just 1% of that market annually, it could fund science with around $50 billion per year.

VitaDAO aims to dictate which fields of science should be funded, including moonshot projects and research not supported by traditional government agencies.

It has already funded 17 projects with approximately $4-5 million, some involving equity and others being late-stage academic projects.

Operates in a distributed fashion, involving members who source and evaluate projects and engage closely with researchers.

They incubate ideas, suggesting experiments and offering support in spinning out companies.

Revenue generated by successful companies is reinvested into the organization for further funding.

The organization plans to initiate projects such as a charity prize, a curated channel for relevant research, and free online symposiums to spread awareness about longevity.

VitaDAO is also working on creating new charity jurisdictions to facilitate medical innovation.

Mentioned in this article:

Click on resource name for more details.

Longevity Med Summit

04-May-2023 to 05-May-2023

Annual gathering of the entire longevity ecosystem to tackle the aging problem

Maximilian Unfried

PhD student at the National University of Singapore applying AI and Complexity Science to Aging Biology and Lipids


World’s first decentralized collective funding early stage longevity research

Topics mentioned on this page:
Investments, Ageing Research
Summary of Max Unfried presentation at Longevity Med Summit